Skip to main content
JIANGSU SIHUAN BIOENGINEERING CO.,LTD logo

JIANGSU SIHUAN BIOENGINEERING CO.,LTD — Investor Relations & Filings

Ticker · 000518 ISIN · CNE0000001P8 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,779 across all filing types
Latest filing 2020-06-15 Director's Dealing
Country CN China
Listing Shenzhen Stock Exchange 000518

About JIANGSU SIHUAN BIOENGINEERING CO.,LTD

https://www.000518shsw.com

Jiangsu Sihuan Bioengineering Co., Ltd. specializes in the research, development, and production of biopharmaceutical products and traditional Chinese medicines. The company’s core product line features genetic engineering drugs, including recombinant human interleukin-2 (rhIL-2) and recombinant human granulocyte colony-stimulating factor (rhG-CSF). Its manufacturing capabilities encompass various dosage forms such as injections, capsules, and tablets, adhering to rigorous quality standards. In addition to its pharmaceutical core, the company manages ecological restoration and landscape engineering initiatives. The organization focuses on leveraging biotechnology to provide therapeutic solutions for oncology and immune-related conditions, maintaining a commitment to scientific innovation and clinical efficacy.

Recent filings

Filing Released Lang Actions
关于实际控制人减持股份比例达到1%的提示性公告
Director's Dealing Classification · 100% confidence The document is a notification about a reduction in shareholding by the actual controller and related parties, specifying the percentage of shares reduced and the method of reduction. It includes detailed tables of shareholding before and after the transaction, compliance statements regarding securities laws, and confirms no change in actual control. There is no financial performance data, earnings information, or management discussion. The document is a formal announcement of a director or major shareholder's share transaction, specifically a reduction in shares held by the actual controller and their related parties. This fits the definition of 'Director's Dealing' (DIRS) as it reports personal share transactions by company directors and executives or controlling shareholders.
2020-06-15 Chinese
独立董事提名人声明（三）
Board/Management Information Classification · 95% confidence The document is a public statement regarding the nomination of an independent director candidate for the company's board. It details the qualifications, compliance with regulatory requirements, and declarations related to the nominee's eligibility and independence. There is no financial data, earnings information, or report publication mentioned. The content focuses on board/management changes and nominations. Therefore, this document fits the category of Board/Management Information (MANG). The document length and content confirm it is not a brief announcement or a regulatory filing but a detailed nomination statement.
2020-06-03 Chinese
独立董事提名人声明（二）
Board/Management Information Classification · 95% confidence The document is a public statement from the nominator regarding the nomination of an independent director candidate for the company's board. It details the qualifications, compliance with regulatory requirements, and declarations related to the nominee's eligibility and independence. There is no financial data, no mention of financial results, no report publication, or voting results. The content is focused on board/management information, specifically about a director nomination. Therefore, the document fits best under the category of Board/Management Information (MANG). The document length and detailed statements support this classification with high confidence.
2020-06-03 Chinese
独立董事候选人声明（徐小娟）
Board/Management Information Classification · 95% confidence The document is a formal declaration by an independent director candidate of Jiangsu Sihuan Bioengineering Co., Ltd. It contains detailed statements about the candidate's qualifications, compliance with relevant laws, regulations, and stock exchange rules, and confirms the absence of conflicts of interest or disqualifying conditions. The content is focused on the candidate's eligibility and independence for a board position rather than financial data, management changes, or shareholder voting results. There is no indication of financial performance, audit results, or meeting materials. This type of document is best classified under Board/Management Information (MANG) as it relates to board member candidacy and governance disclosures.
2020-06-03 Chinese
第八届董事会第二十一次会议决议公告
Board/Management Information Classification · 95% confidence The document is an announcement of the resolutions passed at the 21st meeting of the 8th Board of Directors of Jiangsu Sihuan Bio Co., Ltd. It includes details about the election of the new board members, their biographies, and the voting results. The content focuses on board changes and nominations rather than financial results, audit opinions, or shareholder voting outcomes. It does not contain financial statements or detailed financial analysis. The document length is 3691 characters, which is relatively short and consistent with a board/management announcement. Therefore, the document fits best under the category of Board/Management Information (MANG).
2020-06-03 Chinese
独立董事提名人声明（一）
Board/Management Information Classification · 95% confidence The document is a public statement by the nominator regarding the nomination of an independent director candidate for the company's board. It details the qualifications, compliance with regulatory requirements, and declarations related to the nominee's eligibility and independence. There is no financial data, no mention of financial results, no report publication, or voting results. The content is focused on board/management information, specifically about a board member nomination. Therefore, the document fits best under the category of Board/Management Information (MANG). The document length (6791 characters) supports it being a full statement rather than a brief announcement or certification.
2020-06-03 Chinese

Browse filings by year

29 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.